About Symlux Pharmaceuticals Private Limited
Data last updated:
Symlux Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 09 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2015PTC268271. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Shrikrishna Joshi and Amol Ramdas Nilakh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No – 41/9 Sector – 30 Vashi, Thane, Maharashtra, India – 400705.
As per the financials filed for FY 2023, the company reported a revenue of ₹18,370, a decline of 77% compared to the previous year. For the same year it recorded a net loss of ₹2,810 (net margin -15.3%) and EBITDA of ₹6,570 (EBITDA margin 35.8%). Revenue has declined at a compounded annual rate (CAGR) of 73% over five years.
The company is associated with 1 brand: Symlux Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website symluxpharma.com.
Company details
Contact details
Symlux Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is symluxpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressPlot No – 41/9 Sector – 30 Vashi, Thane, Maharashtra, India – 400705
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Symlux Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Symlux Pharmaceuticals operates one associated brand: Symlux Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of syrup, powder, tablets, capsules, and semi-solid forms | symluxpharma.com |
Financials of Symlux Pharmaceuticals Private Limited
FY 2023 filings availableSymlux Pharmaceuticals Private Limited reported revenue of ₹18,370 (down 77% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 73% over five years, including a 77% fall in the latest year. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,570 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,810 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 35.8% | ||||
| Net Profit Margin | -15.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Symlux Pharmaceuticals Private Limited, buy the company report.
Board of directors of Symlux Pharmaceuticals Private Limited
Symlux Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Shrikrishna Joshi | Director | 23 Mar 2016 | 10 Years 7 Months | Current |
| Amol Ramdas Nilakh Also directs: Ascons Nilakh Plus LLP, Rass Realty LLP | Director | 19 Oct 2015 | 11 Years 0 Months | Current |
Auditor
Symlux Pharmaceuticals Private Limited is audited by JAIN JAGTAP AND ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN JAGTAP AND ASSOCIATES | FY 2018 | 134993W |
Shareholding
The shareholding of Symlux Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Symlux Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Symlux Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Symlux Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Symlux Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Symlux Pharmaceuticals Private Limited, buy the company report.
Recent activity
Symlux Pharmaceuticals Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Santosh Panjabrao Gavhale ceased to be Director on 01 Oct 2022.
Frequently asked questions
Symlux Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 09 September 2015 (11+ years old) and is registered under CIN U74999MH2015PTC268271.
Symlux Pharmaceuticals has 2 current directors:
- Santosh Shrikrishna Joshi - Director
- Amol Ramdas Nilakh - Director
The latest financial statements of Symlux Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
No. Symlux Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Symlux Pharmaceuticals is U74999MH2015PTC268271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Symlux Pharmaceuticals was incorporated on 09 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Santosh Panjabrao Gavhale ceased to be Director on 01 Oct 2022. Vinod Radhakrishnan Nair ceased to be Director on 01 Dec 2018. Amol Ramdas Nilakh ceased to be Additional Director on 30 Sep 2016. Symlux Pharmaceuticals has 6 board changes on record in total.
Symlux Pharmaceuticals can be reached through the website symluxpharma.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Symlux Pharmaceuticals is at Plot No – 419 Sector – 30 Vashi, Thane, Maharashtra, India – 400705.
Symlux Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
